Dedicated to delivering innovative medicines for patients with neuropathic pain.

Neuropathic Pain

Neuropathic pain is a major area of unmet medical need.  It can be caused by trauma to the peripheral or central nervous system, by chemotherapeutics or other drug treatments, or by metabolic disease. The therapeutics currently used to treat neuropathic pain are not sufficiently effective and have poor side-effect profiles.

We are dedicated to delivering innovative medicines for patients with  neuropathic pain.
Development Pipeline

4E is targeting the underlying mechanisms causing pain in neuropathic pain patients. We are developing therapeutics that can transform the lives of people suffering from neuropathic pain.

Leading the charge to a pain free tomorrow.

Leadership Team

Press

November 11, 2021 in Press

4E Therapeutics Awarded NIH Research Grant to Develop Non-Opioid Treatment for Pain to End Addiction

AUSTIN, TX – Nov. 10, 2021 /PRNewswire/ -- 4E Therapeutics, Inc., a neuroscience company based in Austin, Texas developing a first-in-class treatment for neuropathic pain, announced that it has been awarded a…
Read More
October 11, 2019 in Press

4E Therapeutics Receives Grant from NIH

AUSTIN, TX – 4E Therapeutics, Inc., a neuroscience company developing a first-in-class treatment for neuropathic pain, announced that it has been awarded a National Institutes of Health (NIH) Small Business…
Read More